Arbutus Biopharma Corporation ( ABUS) - Key Metrics
ABUS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.02 | -$0.02 | -$0.02 |
| 2025Q3 | $0 | -$0.04 | -$0.03 | -$0.03 |
| 2025Q2 | $0.06 | $0.01 | -$0.08 | -$0.08 |
| 2025Q1 | $0.01 | -$0.13 | -$0.07 | -$0.07 |
ABUS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -61.34 |
| 2025Q3 | ? | -28.12 |
| 2025Q2 | ? | 58.65 |
| 2025Q1 | ? | -6.78 |
ABUS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.93% | ? |
| 2025Q4 | -0.51% | ? |
| 2025Q3 | -0.67% | ? |
| 2025Q2 | -2.66% | ? |
| 2025Q1 | -2.01% | ? |
ABUS
Price: $4.35
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.83 USD
P/E Ratio: 4.99
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 545700
Ebitda: -10.9 millionMarket Capitalization: 859.3 million